ACOG recently issued guidance recommending for the first time that clinicians consider concurrent male sex partner therapy with a combination of topical and oral antimicrobial agents for some women with recurrent bacterial symptomatic vaginosis.The guidance, which ACOG said is backed by “a growing body of evidence implicating sexual activity as a risk factor,” also recommends